Decitabine and Cedazuridine
Decitabine and Cedazuridine | |
---|---|
Term | Decitabine and Cedazuridine |
Short definition | Decitabine and Cedazuridine - (pronounced) (deh-SY-tuh-been. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Decitabine and Cedazuridine - (pronounced) (deh-SY-tuh-been. . . SEE-daz-YOOR-ih-deen) two-drug combination used to treat adults with myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Decitabine stops cells from making DNA, which can help prevent cancer cells from growing and kill them. Cedazuridine prevents decitabine from being broken down in the body, which allows more cancer cells to be killed. Decitabine and cedazuridine are a type of antimetabolite and a type of cytidine deaminase inhibitor. Also called Inqovi
External links
- Medical encyclopedia article on Decitabine and Cedazuridine
- Wikipedia's article - Decitabine and Cedazuridine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski